In vivo programming of dual-targeted CAR-T cells facilitates vascular disruption and T-cell infiltration in solid tumors

T-cell therapies for solid tumors are restricted by abnormal tumor vasculature, which creates structural and immunological barriers to infiltration. Here we report a programmable mRNA lipid nanoparticle (LNP) platform that orchestrates a division-of-labor immune response in vivo. By modulating the LNP nano-bio interface through 10% 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) doping and indirect IgG-based anti-CD5 tethering, we achieve selective and efficient transfection of endogenous splenic T cells. This platform simultaneously generates two complementary chimeric antigen receptor (CAR)-T populations: a vascular endothelial growth factor receptor 2 (VEGFR2)-directed subset that transiently remodels the tumor endothelium, and a tumor-antigen-directed subset that executes cytotoxic clearance. Mechanistic analyses reveal that focal endothelial disruption creates a permissive window for the infiltration, expansion, and activation of tumor-directed CAR-T cells. In refractory melanoma and colorectal carcinoma models in female mice, this dual-programming strategy achieves superior tumor control and drives tumor regression while reducing systemic toxicity. By bypassing ex vivo manufacturing, this approach provides a scalable and host-directed strategy to breach infiltrative barriers in solid-tumor immunotherapy.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-19
DOI
https://doi.org/10.1038/s41467-026-79342-7
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In vivo programming of dual-targeted CAR-T cells facilitates vascular disruption and T-cell infiltration in solid tumors

Shijing Wang, Zhong Sheng Sun, 程晋, Bozhao Li et al.
Nature Communications
CAR-T cell therapy research
article

In vivo programming of dual-targeted CAR-T cells facilitates vascular disruption and T-cell infiltration in solid tumors

Shijing Wang, Zhong Sheng Sun, 程晋, Bozhao Li, Guangjun Nie, Suying Wu, Bo Zhu, Fei Wu, Tianjiao Chu, Zefang Lu, Suping Li, Mengyao Li, Jinna Ren, Lifang Guo, Junsong Huang, Zhouliang Wu, Yuming Fu
article en

Abstract

T-cell therapies for solid tumors are restricted by abnormal tumor vasculature, which creates structural and immunological barriers to infiltration. Here we report a programmable mRNA lipid nanoparticle (LNP) platform that orchestrates a division-of-labor immune response in vivo. By modulating the LNP nano-bio interface through 10% 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) doping and indirect IgG-based anti-CD5 tethering, we achieve selective and efficient transfection of endogenous splenic T cells. This platform simultaneously generates two complementary chimeric antigen receptor (CAR)-T populations: a vascular endothelial growth factor receptor 2 (VEGFR2)-directed subset that transiently remodels the tumor endothelium, and a tumor-antigen-directed subset that executes cytotoxic clearance. Mechanistic analyses reveal that focal endothelial disruption creates a permissive window for the infiltration, expansion, and activation of tumor-directed CAR-T cells. In refractory melanoma and colorectal carcinoma models in female mice, this dual-programming strategy achieves superior tumor control and drives tumor regression while reducing systemic toxicity. By bypassing ex vivo manufacturing, this approach provides a scalable and host-directed strategy to breach infiltrative barriers in solid-tumor immunotherapy.

Nature Communications
Army Medical University (CN), Capital Medical University (CN), Chinese Academy of Sciences (CN), Harbin Institute of Technology (CN), Beijing Chao-Yang Hospital, Capital Medical University (CN), Chinese PLA General Hospital (CN), Xinqiao Hospital (CN), Second Hospital of Tianjin Medical University (CN), National Center for Nanoscience and Technology (CN), Chinese People's Liberation Army (CN), University of Chinese Academy of Sciences (CN), Institute of Zoology (CN), Tianjin Medical University (CN), Beihang University (CN), Ministry of Industry and Information Technology (CN)
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon